Combination Strategies for Immune Checkpoint Inhibitors in PBRM1-mutant Renal Cell Carcinoma: To PARP or Not To PARP?

Elena V. Demidova, Pooja Ghatalia, Sanjeevani Arora

Research output: Contribution to journal › Editorial

2 Scopus citations

Fingerprint

Dive into the research topics of 'Combination Strategies for Immune Checkpoint Inhibitors in PBRM1-mutant Renal Cell Carcinoma: To PARP or Not To PARP?'. Together they form a unique fingerprint.

Medicine and Dentistry